A DNA sequencing machine is one of the most expensive lab purchases a biologist can make. So it is no surprise that, with research funding falling and worse times ahead, institutions are holding off buying the devices, leaving manufacturers feeling the pinch. After a round of gloomy third-quarter results, many makers of sequencing machines are now hoping that cost cutting and expansion into medical diagnostics will help them to prosper again.
展开▼
